Page last updated: 2024-09-05

s 16020-2 and Cancer of Prostate

s 16020-2 has been researched along with Cancer of Prostate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atassi, G; Genissel, P; Goldstein, S; Guilbaud, N; Guillonneau, C; Kraus-Berthier, L; Léonce, S; Parker, T; Pierré, A1

Other Studies

1 other study(ies) available for s 16020-2 and Cancer of Prostate

ArticleYear
Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug.
    Cancer chemotherapy and pharmacology, 2002, Volume: 50, Issue:2

    Topics: Adenocarcinoma; Animals; Animals, Congenic; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Division; Drug Screening Assays, Antitumor; Ellipticines; Enzyme Inhibitors; Female; Humans; Leukemia P388; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Nude; Mice, SCID; Neoplasm Proteins; Organ Specificity; Ovarian Neoplasms; Prodrugs; Prostatic Neoplasms; Topoisomerase II Inhibitors; Vinblastine; Vinorelbine; Xenograft Model Antitumor Assays

2002